D68.61
Antiphospholipid syndrome
Risk-adjusting (HCC)Billable code
HCC risk adjustment mapping
CMS-HCC ESRD V24
HCC48
Coagulation Defects and Other Specified Hematological Disorders
Coding notes
Excludes 1 never coded together · Excludes 2 may co-exist
This code · D68.61
Inherited from D68.6Other thrombophilia
Inherited from D68Other coagulation defects
Inherited from chapter 3Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Excludes 2
autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Official Guidelines for D68.61
FY 2026 ›Find D68.61 in the alphabetic index
9 index paths lead to this code
- Anticardiolipin syndrome
- Syndrome › anticardiolipin
- Syndrome › antiphospholipid
- Antiphospholipid › antibody › syndrome
- Antibody › anticardiolipin › with › hypercoagulable state
- Antibody › antiphosphatidylglycerol › with › hypercoagulable state
- Antibody › antiphosphatidylinositol › with › hypercoagulable state
- Antibody › antiphosphatidylserine › with › hypercoagulable state
- Antibody › antiphospholipid › with › hypercoagulable state